The tender offer period has expired, and the results of the tender offer have been confirmed. Upon application to the Shanghai Stock Exchange, the shares of Liaoning Chengda Biotechnology Co., Ltd. will resume trading from the market opening on April 8, 2025.
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment